Basics Vaxcyte, Inc. IPO Date: July 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $5.57B Activated in VL: True Average Daily Range Avg Daily Range: $1.02 | 2.53% Avg Daily Range (30 D): $0.91 | 2.48% Avg Daily Range (90 D): $0.69 | 1.98% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): 1.62M Avg Daily Volume (90 D): 1.27M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 3,560 Avg Inst. Trade: $3.72M Avg Inst. Trade (30 D): $3.55M Avg Inst. Trade (90 D): $3.63M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $7.43M Avg Closing Trade (30 D): $10.51M Avg Closing Trade (90 D): $9.26M Avg Closing Volume: 141.59K     News Sep 30, 2025 @ 3:42 PM Thermo Fisher Launches Four-Part Bond Offering Ahe... Source: Vandana Singh Aug 21, 2025 @ 5:00 PM Pneumococcal Infections Clinical Trial Analysis: K... Source: Delveinsight Aug 7, 2025 @ 12:19 AM Vaxcyte (PCVX) Q2 Loss Widens 11% Source: Jesterai Mar 31, 2025 @ 12:56 PM Vaxcyte Plans To Drop Developing One Pneumococcal ... Source: Vandana Singh Jan 30, 2025 @ 4:51 PM Kuehn Law Encourages Investors of Vaxcyte, Inc. to... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-4.11 $-1.22 $-1.04 Diluted EPS $-4.11 $-1.22 $-1.04 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -547.5M $ -166.57M $ -140.72M Operating Income / Loss $ -709.11M $ -226.22M $ -180.79M Cost of Revenue $ $ $ Net Cash Flow $ -211.71M $ -40.11M $ -41.03M PE Ratio